Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-009405

EVP & Chief Financial Officer gave up 4,819 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
MCGRATH JOHN EVP & Chief Financial Officer 2018-02-09 Shares withheld for taxes −4,819 $41.70 $200,952 105,556 D: show line 1 in the form
Loading xslF345X03/doc4.xml…